These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23373312)

  • 1. [The lipid metabolism abnormality in patients administered with olanzapine].
    Amano T; Hosaka S; Takami H; Sugiyama C; Oda K; Morikawa R
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):257-61. PubMed ID: 23373312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.
    Yasui-Furukori N; Sato Y; Furukori H; Saito M; Nakagami T; Kaneko S
    J Clin Psychiatry; 2009 Jan; 70(1):95-100. PubMed ID: 19026267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.
    Guina J; Roy S; Gupta A; Langleben DD; Elman I
    Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28573760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol.
    Krakowski M; Czobor P; Citrome L
    Schizophr Res; 2009 May; 110(1-3):95-102. PubMed ID: 19269139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
    Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
    J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
    Smith RC; Lindenmayer JP; Hu Q; Kelly E; Viviano TF; Cornwell J; Vaidhyanathaswamy S; Marcovina S; Davis JM
    Schizophr Res; 2010 Jul; 120(1-3):204-9. PubMed ID: 20457512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia.
    Hosojima H; Togo T; Odawara T; Hasegawa K; Miura S; Kato Y; Kanai A; Kase A; Uchikado H; Hirayasu Y
    J Psychopharmacol; 2006 Jan; 20(1):75-9. PubMed ID: 16204328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 2000 Oct; 61(10):742-9. PubMed ID: 11078035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of ziprasidone and olanzapine on glucose and lipid metabolism in first-episode schizophrenia].
    Shao P; Ou J; Wu R; Fang M; Chen H; Xu Y; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):365-9. PubMed ID: 23645236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophrenia.
    Baptista T; Dávila A; El Fakih Y; Uzcátegui E; Rangel NN; Olivares Y; Galeazzi T; Vargas D; Peña R; Marquina D; Villarroel V; Teneud L; Beaulieu S
    Int Clin Psychopharmacol; 2007 Jul; 22(4):205-11. PubMed ID: 17519643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents.
    Melkersson KI; Hulting AL
    Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin.
    Lu ML; Wang TN; Lin TY; Shao WC; Chang SH; Chou JY; Ho YF; Liao YT; Chen VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():47-50. PubMed ID: 25496829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population.
    Perez-Iglesias R; Mata I; Pelayo-Teran JM; Amado JA; Garcia-Unzueta MT; Berja A; Martinez-Garcia O; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2009 Feb; 107(2-3):115-21. PubMed ID: 18993033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
    Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
    Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A crossover study on the glucose metabolism between treatment with olanzapine and risperidone in schizophrenic patients.
    Sato Y; Yasui-Furukori N; Furukori H; Saito M; Nakagami T; Kaneko S
    Exp Clin Psychopharmacol; 2010 Oct; 18(5):445-50. PubMed ID: 20939648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
    Smith GC; Vickers MH; Shepherd PR
    Arch Physiol Biochem; 2011 Oct; 117(4):241-9. PubMed ID: 21671852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.
    Tsuneyama N; Suzuki Y; Sawamura K; Sugai T; Fukui N; Watanabe J; Ono S; Saito M; Someya T
    PLoS One; 2016; 11(3):e0149518. PubMed ID: 26930407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
    Murashita M; Inoue T; Kusumi I; Nakagawa S; Itoh K; Tanaka T; Izumi T; Hosoda H; Kangawa K; Koyama T
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):54-8. PubMed ID: 17239039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients.
    Smith RC; Lindenmayer JP; Bark N; Warner-Cohen J; Vaidhyanathaswamy S; Khandat A
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):183-94. PubMed ID: 15737248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.